Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Open Forum Infectious Diseases
|
November 8, 2022
Discriminatory Ability of Gas Chromatography-Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis
Joshua Nazareth, Daniel Pan, Jee Whang Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 16, 2024
Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral "Triggers" Tool for outpatients with cancer
Laila Kamal, Yuki Kano, Anna-Marie Stevens, et al.
Plos One
|
December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)
Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.
Eclinicalmedicine
|
August 26, 2020
Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study
Christopher A Martin, David R Jenkins, Jatinder S Minhas, et al.
Journal of Medicinal Chemistry
|
April 6, 2019
Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, et al.
International Journal of Molecular Sciences
|
November 25, 2023
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
Andreas Jekle, Santosh Kumar Thatikonda, Ruchika Jaisinghani, et al.
Journal of Medicinal Chemistry
|
August 21, 2020
Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of <b>AL-611</b> as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, et al.
Neurobiology of Disease
|
November 9, 2018
Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease
Jérôme Lamontagne-Proulx, Isabelle St-Amour, Richard Labib, et al.
Journal of Medicinal Chemistry
|
September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
Koen Vandyck, David C McGowan, Xuan G Luong, et al.
BMJ Open
|
December 2, 2024
Defining within-host SARS-CoV-2 RNA viral load kinetics during acute COVID-19 infection within different respiratory compartments and their respective associations with host infectiousness: a protocol for a systematic review and meta-analysis
Daniel Pan, Christopher A Martin, Joshua Nazareth, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Open Forum Infectious Diseases
|
November 8, 2022
Discriminatory Ability of Gas Chromatography-Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis
Joshua Nazareth, Daniel Pan, Jee Whang Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 16, 2024
Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral "Triggers" Tool for outpatients with cancer
Laila Kamal, Yuki Kano, Anna-Marie Stevens, et al.
Plos One
|
December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)
Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.
Eclinicalmedicine
|
August 26, 2020
Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study
Christopher A Martin, David R Jenkins, Jatinder S Minhas, et al.
Journal of Medicinal Chemistry
|
April 6, 2019
Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, et al.
International Journal of Molecular Sciences
|
November 25, 2023
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
Andreas Jekle, Santosh Kumar Thatikonda, Ruchika Jaisinghani, et al.
Journal of Medicinal Chemistry
|
August 21, 2020
Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of <b>AL-611</b> as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, et al.
Neurobiology of Disease
|
November 9, 2018
Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease
Jérôme Lamontagne-Proulx, Isabelle St-Amour, Richard Labib, et al.
Journal of Medicinal Chemistry
|
September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
Koen Vandyck, David C McGowan, Xuan G Luong, et al.
BMJ Open
|
December 2, 2024
Defining within-host SARS-CoV-2 RNA viral load kinetics during acute COVID-19 infection within different respiratory compartments and their respective associations with host infectiousness: a protocol for a systematic review and meta-analysis
Daniel Pan, Christopher A Martin, Joshua Nazareth, et al.
Page
of 8